Navigation Links
Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
Date:5/9/2008

or year quarter, a decrease of $60.7 million. During the quarter ended March 31, 2008 we made payments in respect of income taxes totaling $69.3 million as compared to $0.2 million in the prior year quarter. The payments made during the quarter ended March 31, 2008 were made primarily based upon: (1) estimates of the amounts payable in connection with the anticipated final settlement of U.S. federal tax audits for prior periods, (2) estimates of U.S. federal income taxes for the 2007 and 2008 tax years and (3) amended income tax returns for the 2006 tax year resulting from the APA signed with the IRS.

2008 Financial Guidance Update

Based on the first quarter results and current outlook for the remainder of 2008, the Company is updating its full year 2008 financial guidance. For 2008, the Company continues to anticipate revenue to be in the range of $935 to $945 million.

Total SG&A expenses are now expected to be in the range of $223 to $232 million, a decrease of $5 million from the original guidance given in January 2008. This reflects a decrease in estimated advertising and promotional expenses.

In addition, the Company now anticipates that its income tax provision in 2008 will be in the range of 5.5% to 6.5% of earnings before taxes and book amortization ("EBTA"). The guidance includes the Company's latest estimate of pretax income by tax jurisdiction, as well as the impact of the Company's recently signed APA with the IRS.

Based on the revised guidance, GAAP net income is expected to be in the range of $129 to $142 million. CNI, which adds back the after tax impact of book amortization of intangible assets and the amortization and write off of deferred financing costs, is expected to be in the range of $326 to $339 million. Using 251.0 million Class A common shares, the Company expects CNI per share to be in the range of $1.30 to $1.35 for the full year 2008.

Investor Conference Call

The Company is hosting a confe
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
2. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
3. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2007 Financial Results
4. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
5. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
6. Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
7. Warner Chilcott Reports the Death of Its Director James Andress
8. Mark Whitacre, Ph.D. Promoted at Cypress Systems, Inc. and a Warner Brothers Movie to Be Filmed About Him
9. Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2008 Financial Results
10. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
11. QMed, Inc. Reports July Medicare SNP Enrollments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015 /CNW/ - Resverlogix Corp. ... on RVX-208 was presented at the ERA-EDTA Congress in ... entitled: "Effects of RVX-208, a First-in-Class Epigenetic BET-Inhibitor, on ... CVD, and Chronic Kidney Disease (CKD); a Post-hoc Analysis ... Trials." Dr. Kam Kalantar-Zadeh , ...
(Date:6/1/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lkcspr/2015_strategies ... "2015 Strategies in European Immunoprotein Diagnostic ... This new 273-page report provides ... including emerging tests, technologies, instrumentation, sales forecasts, ... suppliers. Companies Mentioned: - ...
(Date:6/1/2015)... DIEGO , June 1, 2015  OncoSec ... company developing DNA-based intratumoral cancer immunotherapies, today announced ... Davis) School of Veterinary Medicine to test ImmunoPulse™ ... tissue sarcoma. The primary goals of the canine ... mechanism of action of ImmunoPulse™ IL-12 and validate ...
(Date:6/1/2015)... 1, 2015 Hutchison China ... AstraZeneca AB (publ) ("AstraZeneca"), Hutchison MediPharma Limited,s ("HMP") ... Phase Ib clinical trial of HMP,s c-Met inhibitor ... in non-small cell lung cancer ("NSCLC"). ... growth factor receptor (EGFR). Preliminary data on the ...
Breaking Biology Technology:Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 2Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 3Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 4OncoSec Medical and UC Davis School of Veterinary Medicine Collaborate to Test Intratumoral Cancer Immunotherapy in Canine Soft Tissue Sarcoma 2OncoSec Medical and UC Davis School of Veterinary Medicine Collaborate to Test Intratumoral Cancer Immunotherapy in Canine Soft Tissue Sarcoma 3OncoSec Medical and UC Davis School of Veterinary Medicine Collaborate to Test Intratumoral Cancer Immunotherapy in Canine Soft Tissue Sarcoma 4Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 3
... on the Comprehensive Microbial Resource enable researchers to quickly and effectively ... ... December 10, 2008 -- OpenHelix today announced the availability ... CMR is a public resource for the analysis of ...
... of growing computing power could be sustained for many ... the UK,s National Physical Laboratory (NPL) that is applying ... that the density of transistors on an integrated circuit ... to achieve this, but experts believed that when the ...
... Transgenomic, Inc.,(OTC Bulletin Board: TBIO) today announced that ... Commission on Laboratory Accreditation of the,College of American ... recent,on-site inspection. Transgenomic is now one of the ... Craig Tuttle, CEO of Transgenomic, said, "We are ...
Cached Biology Technology:New Online Tutorial for the Comprehensive Microbial Resource (CMR) 2Transgenomic Receives Accreditation From College of American Pathologists 2Transgenomic Receives Accreditation From College of American Pathologists 3
(Date:5/7/2015)... Fingerprint Cards (FPC) introduces ... FPC,s smallest touch fingerprint sensors to date.  ... integration on the backside of the phone, and ... to integrate touch fingerprint sensors in the OEMs, ... for module manufacturers to customize the look and ...
(Date:4/27/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces that its Wocket® Smart ... week of May, 2015 and will be fulfilling all ... Gino Pereira , Chief Executive Officer said, ... Wocket® enters the consumer market. We would like to ...
(Date:4/20/2015)... The announcement comes as demand for fire vault ... Ireland,s foremost records management company, has secured ... impressive track record of clients within the first 12 months, ... sector in Dubai . As a result, ... a further eight staff members at its Irish headquarters. The ...
Breaking Biology News(10 mins):FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3
... A major public symposium at Boston College will bring together ... the contributions of the physical and social sciences to a ... the Liberal Arts University Why It Matters to Us ... for the Liberal Arts, takes place today at the University,s ...
... still the primary treatment for halting the spread ... resistance is now outpacing the rate of new ... University of Wisconsin-Milwaukee (UWM) has discovered a different ... disarm them, quashing disease without the worry of ...
... A study led by Matej Oreič from ... autoimmune diabetes is preceded by diminished gut microbial ... leptin and enhanced glucose-stimulated insulin secretion. In ... Diabetes and Prediction study, VTT researches have previously ...
Cached Biology News:Science in the liberal arts university 2An antibiotic effect minus resistance 2An antibiotic effect minus resistance 3VTT identified specific bacteria which precede autoimmune diabetes 2
... Sepharose High Performance, 5 ml. The ... in HiTrap Streptavidin columns for fast, ... packing into Tricorn 5/50 GL, XK ... scale purifications are required.Extremely useful for ...
...
...
...
Biology Products: